The AI healthcare market has grown a lot in the past few years. In 2024, the global AI healthcare market was worth about USD 26.57 billion. It is expected to reach around USD 187.69 billion by 2030. This means it will grow fast, at about 38.62% each year from 2025 to 2030. North America, especially the United States, has more than 54% of this market. This is mainly because of advanced healthcare IT systems, government actions, and wide use of AI and machine learning.
In this market, software solutions make up the biggest part, with over 46% of the revenue in 2024. This is because AI software is used in many clinical and administrative healthcare tasks. Unlike hardware, like robots for surgery, AI software can be used easily in many healthcare places, from small clinics to large hospitals.
Clinical trials are often complicated, slow, and costly. AI software is changing this by making processes faster and improving how patients are recruited. In the United States, Johnson & Johnson uses AI-driven software to find clinical trial sites and recruit patients from different areas and backgrounds. This helps bring trials to the patients instead of waiting for patients to travel to main centers.
The software uses machine learning to look at large sets of anonymous health data. It finds possible trial participants based on certain rules. This helps cut down the time it takes to get patients into trials. The AI also helps design better trials by choosing sites that are ready and have the right kinds of patients for the study.
This software not only speeds up patient recruitment but also improves diversity in clinical trials. For healthcare managers, this means smoother trial operations and results that apply to more patient groups. AI also gives information on how well patients stay in trials and follow the rules, which helps make trials successful and get approval from regulators.
AI software tools have made big improvements in diagnostics. In 2024, machine learning technologies made up more than 35% of the AI healthcare technology market. These tools help analyze electronic health records, medical images, genetics, and other medical data to make diagnoses more accurate and faster.
Medical imaging benefits a lot from AI software that can quickly analyze images in detail. AI can find small changes or problems in scans that people might miss. So far in 2024, the Food and Drug Administration (FDA) has approved over 1,200 AI or machine learning medical devices in the U.S. This shows that these AI devices are safe and work well in clinics.
One example is Johnson & Johnson’s Polyphonic™ system. It uses AI to analyze surgery videos and helps surgeons make decisions during operations. This software also supports telepresence, so surgical experts can work together from different places. AI software helps both diagnosis and surgery planning.
Personalized medicine is another area helped by AI software. For example, AI looks at biopsy images to find gene changes, like FGFR mutations in bladder cancer. These findings help doctors give targeted treatments that fit each patient’s needs better.
AI software also helps manage healthcare operations. Practice managers and IT staff use AI tools to handle routine tasks like scheduling appointments, billing, talking with patients, and processing insurance claims.
Using AI for operations lowers the amount of manual work. This lets healthcare workers spend more time caring for patients, not paperwork. This is important because the U.S. may lack about 10 million healthcare workers by 2030. Automating tasks helps handle this shortage and improves how organizations run.
Fraud detection is one important area in operations. Healthcare fraud raises costs and lowers trust. AI systems use pattern recognition to find suspicious claims or bills quickly and accurately. This protects money and helps meet legal rules.
Johnson & Johnson also uses AI for supply chain management. The software predicts supply delays and helps plan delivery schedules. It looks at market trends, logistics, and demand changes. This helps make sure medical products are available when needed, especially in emergencies like the COVID-19 pandemic.
Many healthcare offices have routine tasks like answering phone calls, managing appointments, and guiding patient questions. AI software is changing these jobs by offering smart phone answering and automation.
Companies like Simbo AI offer AI phone automation that lowers staff work and improves how patients communicate. This is helpful in the U.S., where good admin work affects patient satisfaction.
AI answering systems can handle many calls, sort patient questions, schedule callbacks, and send urgent questions to the right medical staff quickly and correctly. This makes the office run more smoothly with fewer missed calls and faster replies. These systems work well in busy places like clinics and hospital front desks.
Simbo AI and similar services connect with Electronic Health Records and practice management systems. They keep patient data secure and use it right during calls. This helps follow rules about patient privacy like HIPAA and keeps data flowing smoothly.
AI tools also help send appointment reminders and follow-ups. This lowers the chances patients miss appointments and keeps them involved in their care. For IT managers, these tools make systems simpler by combining communication tasks, so they can focus on other tech needs.
Since AI software is leading in healthcare, medical practice leaders need to understand and use these technologies well. The software is flexible and can fit small clinics or big hospitals.
Managers can use AI software to help with clinical trials, improve diagnoses using machine learning, and make daily work run better with automation and fraud detection. These tools help use resources wisely, raise care quality, and improve money management.
Because of expected staff shortages, using AI software to speed up work is very important. Automation cuts down worker burnout and lets staff spend more time with patients. This fits with national goals to improve healthcare while keeping costs low.
IT managers have a key role in adding AI software to current systems. They make sure data is safe, rules are followed, and old systems work well with new AI tools. Teams in clinical and admin areas need to work together to pick AI solutions that fit their needs without causing problems.
The U.S. has strong healthcare IT systems that support AI use in software. Government programs back AI development and have rules that confirm AI tools are safe and effective. For example, the FDA’s approval of over 1,200 AI devices helps bring AI into clinics faster and builds trust in the technology.
Tech companies and healthcare groups work together to speed up AI software growth. Microsoft partners with NVIDIA to use cloud computing and AI for research and diagnostics. Medtronic uses AI assistants to reduce clinician burnout by automating admin tasks. This is similar to what companies like Simbo AI offer for front-office automation.
These partnerships show that AI software will keep playing a central role in changing healthcare in the U.S. It supports better clinical trial management, more accurate diagnoses, improved operations, and stronger patient engagement.
Developing and using AI software in these areas provides U.S. healthcare workers with useful tools to keep up with changing needs. Medical practice leaders, owners, and IT staff should know how to use these tools to help keep healthcare systems running well and patient care strong.
The global AI in healthcare market size was estimated at USD 26.57 billion in 2024, reflecting significant growth driven by demands for efficiency, accuracy, and improved patient outcomes.
The market is expected to grow at a CAGR of 38.62% from 2025 to 2030, reaching a projected size of USD 187.69 billion by 2030 due to expanding AI adoption across healthcare sectors.
North America dominated with over 54% revenue share in 2024, driven by advanced healthcare IT infrastructure, favorable government initiatives, and widespread adoption of AI/ML technologies.
Major drivers include the need for enhanced efficiency and accuracy in healthcare delivery, increasing patient outcome demands, healthcare workforce shortages projected at 10 million by 2030, supportive government policies, and pandemic-induced acceleration in AI applications.
Software solutions dominated with over 46% revenue share in 2024, due to rapid adoption of AI-based software by providers, payers, and patients for clinical trials, diagnostics, and operational efficiency.
Robot-assisted surgery led the application segment with 13% revenue share in 2024, supported by growing surgical robotics adoption and investment. Fraud detection is projected to grow fastest, fueled by healthcare fraud concerns and advanced analytical techniques.
Machine learning accounted for over 35% of the market in 2024, excelling in analyzing vast healthcare data sets like EHRs, medical imaging, and genomics to improve diagnoses, prognosis, and personalized treatment.
AI-powered tools improve diagnostic accuracy and reduce interpretation time in medical imaging, enhance predictive analytics for patient admissions, and optimize resource allocation, thus boosting patient care quality and operational efficiency.
Major companies include Microsoft, IBM, Google, NVIDIA Corporation, Intel Corporation, GE Healthcare, Medtronic, Oracle, Medidata, Merck, and IQVIA, driving innovation through partnerships, mergers, and AI-based product development.
Recent advances include funding for AI virtual care platforms, AI assistants to reduce clinician burnout, AI-powered operating rooms, NVIDIA’s generative AI microservices for MedTech, and collaborations enhancing drug discovery and diagnostics, highlighting AI’s expanding clinical and operational impact.